Lifecore Biomedical, Inc. \De\ (LFCR) Gross Margin (2010 - 2025)
Lifecore Biomedical, Inc. \De\ (LFCR) posted quarterly Gross Margin of 38.37% for Q2 2025, down 722.0% year-over-year from 6.17% in Q2 2024, and up 36.99% quarter-over-quarter from 28.01% in Q1 2025.
Lifecore Biomedical, Inc. \De\ (LFCR) Gross Margin (2010 - 2025) Analysis & Trends
Lifecore Biomedical, Inc. \De\'s Gross Margin history runs 16 years deep, the most recent figure standing at 38.37% for Q2 2025.
- In Q2 2025, Gross Margin fell 722.0% year-over-year to 38.37%; the TTM figure through May 2025 stood at 31.27% (down 136.0% YoY), while the FY2025 annual figure was 31.27%, down 136.0% from the prior year.
- Gross Margin for Q2 2025 stood at 38.37%, up from 28.01% in the prior quarter.
- The five-year high for Gross Margin was 45.59% in Q2 2024, with the low at 11.12% in Q3 2023.
- The 5-year median for Gross Margin is 32.74% (2023), against an average of 31.39%.
- The sharpest annual moves came in 2021 and 2022: Gross Margin soared 2620 bps in 2021, then sank 1878 bps in 2022.
- Lifecore Biomedical, Inc. \De\'s Gross Margin stood at 44.76% in 2021, then sank by 42 bps to 25.97% in 2022, then increased by 27 bps to 33.02% in 2023, then gained by 3 bps to 34.04% in 2024, then rose by 13 bps to 38.37% in 2025.
- Business Quant data shows LFCR's Gross Margin at 38.37% in Q2 2025, 28.01% in Q1 2025, and 34.04% in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 25, 2025 | 38.37% |
| Feb 23, 2025 | 28.01% |
| Nov 24, 2024 | 34.04% |
| Aug 25, 2024 | 21.81% |
| May 26, 2024 | 45.59% |
| Feb 25, 2024 | 33.31% |
| Nov 26, 2023 | 33.02% |
| Aug 27, 2023 | 11.12% |
| May 28, 2023 | 24.98% |
| Feb 26, 2023 | 32.21% |
| Nov 27, 2022 | 25.97% |
| Aug 28, 2022 | 25.20% |
| May 29, 2022 | 37.09% |
| Feb 27, 2022 | 33.04% |
| Nov 28, 2021 | 44.76% |
| Aug 29, 2021 | 24.83% |
| May 30, 2021 | 32.46% |
| Feb 28, 2021 | 39.31% |
| Nov 29, 2020 | 45.28% |
| Aug 30, 2020 | 23.35% |